Copyright
©The Author(s) 2018.
World J Gastroenterol. Dec 7, 2018; 24(45): 5063-5075
Published online Dec 7, 2018. doi: 10.3748/wjg.v24.i45.5063
Published online Dec 7, 2018. doi: 10.3748/wjg.v24.i45.5063
Table 1 Comparison of experimental models of alcoholic liver disease
| Models | Animal model | Characteristics | Advantages and disadvantages |
| Lieber-DeCarli liquid diet[27,28] | Rat/mice | Chronic ethanol feeding (4-12 wk) | Easy to perform |
| Marked elevation of ALT | |||
| Short term feeding with no mortality rate | |||
| No liver fibrosis | |||
| Rat/mice | Chronic ethanol feeding + single/multiple binges (4-6 wk) | Easy to perform | |
| Marked elevation of ALT and marked steatosis | |||
| Long term feeding + multiple binges with a high mortality rate | |||
| No liver fibrosis | |||
| Rat/mice | + Second hit: DEN, LPS, CCl4, APAP (4-12 wk) | Easy to perform | |
| Marked elevation of ALT and marked steatosis | |||
| Long term feeding + multiple binges + injection with a high mortality rate | |||
| Liver fibrosis | |||
| Ethanol ad libitum feeding[27,28] | Mice | Oral alcohol in drinking water (10 d/1-2 wk) | Easy to perform |
| Minimal elevation of ALT and mild steatosis | |||
| Short-or long-term feeding with no mortality rate | |||
| No liver fibrosis | |||
| The Tsukamoto-French model[27,28] | Rat/mice | Intragastric infusion (2-3 mo) | Difficult to perform |
| Requirement for intensive medical care | |||
| Marked elevation of ALT and steatosis | |||
| Long-term feeding with a high mortality rate | |||
| Mild liver fibrosis | |||
| The NIAA model[47] | Mice | LDE + single ethanol binge | Cost and time efficient |
| High blood alcohol levels | |||
| Liver injury | |||
| Inflammation | |||
| Fatty liver | |||
| Rat /mice | LDE + 3 ethanol binges | Cost and time efficient | |
| Increased blood alcohol levels | |||
| Augmented liver injury | |||
| Increases in ERK1/2 | |||
| Ethanol + CCl4 treatment[106] | Mice | 4% ethanol liquid diet + 2 times IP CCl4 injection per week (8 wk) | Easy to perform |
| Toxic components | |||
| Elevated acetaldehyde levels | |||
| Liver fibrosis |
- Citation: Lamas-Paz A, Hao F, Nelson LJ, Vázquez MT, Canals S, Gómez del Moral M, Martínez-Naves E, Nevzorova YA, Cubero FJ. Alcoholic liver disease: Utility of animal models. World J Gastroenterol 2018; 24(45): 5063-5075
- URL: https://www.wjgnet.com/1007-9327/full/v24/i45/5063.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i45.5063
